Gyrase Inhibitors – Mechanism, Uses & Side Effects
Gyrase inhibitors are antibiotics that block bacterial enzymes essential for DNA replication, effectively killing bacteria. They are used to treat a wide range of bacterial infections.
Wissenswertes über "Gyrase Inhibitors"
Gyrase inhibitors are antibiotics that block bacterial enzymes essential for DNA replication, effectively killing bacteria. They are used to treat a wide range of bacterial infections.
What Are Gyrase Inhibitors?
Gyrase inhibitors – also known as fluoroquinolones or quinolones – are a class of antibiotics that interfere with bacterial DNA replication. They inhibit two key bacterial enzymes: DNA gyrase (topoisomerase II) and topoisomerase IV. These enzymes are essential for controlling the winding and unwinding of bacterial DNA during cell division. Without them, bacteria cannot replicate and ultimately die.
Mechanism of Action
Bacterial DNA exists in a tightly coiled (superhelical) form. DNA gyrase regulates these coils, enabling DNA replication and transcription to proceed. Gyrase inhibitors bind to the enzyme-DNA complex and block its activity, causing double-strand breaks in the bacterial DNA. This leads to bacterial cell death. Because they kill bacteria directly rather than simply halting their growth, gyrase inhibitors are classified as bactericidal agents.
Indications – When Are Gyrase Inhibitors Used?
Gyrase inhibitors are prescribed for a wide range of bacterial infections, including:
- Urinary tract infections (e.g., caused by Escherichia coli)
- Respiratory tract infections (e.g., community-acquired pneumonia)
- Skin and soft tissue infections
- Gastrointestinal infections (e.g., traveler's diarrhea, salmonellosis)
- Bone and joint infections
- Sexually transmitted infections (e.g., gonorrhea)
- Tuberculosis (as reserve antibiotics in cases of drug resistance)
Key Active Ingredients
The most widely used gyrase inhibitors include:
- Ciprofloxacin – the most commonly prescribed fluoroquinolone
- Levofloxacin – frequently used for respiratory infections
- Moxifloxacin – effective against anaerobes and atypical pathogens
- Norfloxacin – primarily used for urinary tract infections
- Ofloxacin – broad spectrum, including ophthalmic infections
Dosage
Dosage varies depending on the specific agent, indication, and severity of infection. Gyrase inhibitors are available as tablets, intravenous infusions, and in some cases as eye drops or ear drops. The exact dosage and duration of treatment should always be determined by a healthcare professional. Patients should complete the full course of therapy to prevent the development of antibiotic resistance.
Side Effects
Gyrase inhibitors can cause a range of side effects. Common side effects include:
- Gastrointestinal symptoms (nausea, diarrhea, abdominal pain)
- Headache and dizziness
- Sleep disturbances
Rare but serious side effects include:
- Tendon damage – particularly Achilles tendon rupture (especially in elderly patients and those taking corticosteroids concurrently)
- Neuropsychiatric effects – including anxiety, confusion, hallucinations, or depression
- QT interval prolongation – a cardiac arrhythmia risk, particularly relevant in patients with pre-existing heart conditions
- Photosensitivity – increased sensitivity of the skin to sunlight
- Peripheral neuropathy – nerve damage that may manifest as tingling or numbness in the extremities
Due to the potential for serious adverse effects, European and international health authorities recommend using gyrase inhibitors only when no suitable alternative antibiotics are available.
Contraindications and Interactions
Gyrase inhibitors should not be used in:
- Children and adolescents who are still growing (risk of cartilage damage)
- Pregnant or breastfeeding women
- Patients with known hypersensitivity to quinolones
- Patients with epilepsy or seizure disorders (increased risk of convulsions)
Important drug interactions include:
- Antacids, iron, and zinc supplements (reduce absorption of gyrase inhibitors)
- Anticoagulants such as warfarin (increased bleeding risk)
- Other medications that affect heart rhythm
Antibiotic Resistance
The widespread and sometimes indiscriminate use of gyrase inhibitors has led to a significant increase in antibiotic resistance against this drug class over recent decades. Resistant strains of gram-negative bacteria such as Escherichia coli and Klebsiella pneumoniae are of particular concern. Responsible use in accordance with medical prescription is therefore essential to preserve the effectiveness of these antibiotics.
References
- European Medicines Agency (EMA): Fluoroquinolone- and quinolone-containing medicinal products. Restrictions on use. EMA/175739/2019.
- World Health Organization (WHO): Critically important antimicrobials for human medicine. 6th revision. Geneva, 2019.
- Brunton, L. L. et al.: Goodman & Gilman's The Pharmacological Basis of Therapeutics. 13th edition. McGraw-Hill Education, New York, 2017.
Verwandte Produkte
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
Best-selling products
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryHuman Pegivirus
Haemophilus paraphrophilus
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Cologne list
Calorie content
Related search terms: Gyrase Inhibitors + Gyrase Inhibitor + Gyrase-Inhibitors